Health & Wellness Today New York
SEE OTHER BRANDS

Get your fresh news on health and wellness in New York

Health & Wellness Today New York: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health & Wellness Today New York.

Press releases published on May 30, 2025

NYC Optician French Optical Fashion, Inc. Educates on Eye Wellness

NYC Optician French Optical Fashion, Inc. Educates on Eye Wellness

French Optical Fashion, Inc. launches NYC optician campaign to promote eye health with exams and education. NEW YORK, NY, UNITED STATES, May 30, 2025 /⁨EINPresswire.com⁩/ -- French Optical Fashion, Inc., a premier NYC optician located at 7 East 33rd St., …

Christian Health Expert Ondrea Lynn Empowers Women with Bold New Book on Faith-Based Weight Loss Strategy

Christian Health Expert Ondrea Lynn Empowers Women with Bold New Book on Faith-Based Weight Loss Strategy

With a mission to help Christian women reclaim their health and rise into their God-given purpose! HIGHLAND, NY, UNITED STATES, May 30, 2025 /⁨EINPresswire.com⁩/ -- Christian women across the globe are about to gain a powerful new tool in their health and …

The Brookbush Institute Publishes NEW Course: Acute Variables: Periodization Training

The Brookbush Institute Publishes NEW Course: Acute Variables: Periodization Training

The Brookbush Institute continues to enhance education with new courses, a modern glossary, an AI Tutor, and a client program generator. NEW YORK, NY, UNITED STATES, May 30, 2025 /⁨EINPresswire.com⁩/ -- - Related Course: Acute Variables: Periodization …

CABS Health Network and CookUnity Launch Medicaid Meal Initiative to Tackle Food Insecurity in New York City

CABS Health Network and CookUnity Launch Medicaid Meal Initiative to Tackle Food Insecurity in New York City

BROOKLYN, NY, UNITED STATES, May 30, 2025 /⁨EINPresswire.com⁩/ -- CABS Health Network is proud to announce a groundbreaking partnership with CookUnity, the only premium 100% chef-crafted meal delivery service, to launch a new Medicaid-covered initiative …

Hydreight Reports 34% Year-Over-Year Q1 Revenue Growth, Improvement in Bottom Line Results, and Delivers Strong Performance Across Verticals

Hydreight Reports 34% Year-Over-Year Q1 Revenue Growth, Improvement in Bottom Line Results, and Delivers Strong Performance Across Verticals

“It was an outstanding quarter. We exceeded our Q1 projections with approximately 34% YOY growth from our first two verticals, a clear sign that our strategy is working. We also secured new customers for VSDHOne, positioning us strongly to hit our year-end …

Early Warning Press Release Respecting the Acquisition of Common Shares of RAMM PHARMA Corp.

Early Warning Press Release Respecting the Acquisition of Common Shares of RAMM PHARMA Corp.

TORONTO, May 30, 2025 (GLOBE NEWSWIRE) -- Jack Burnett ("CEO") today announced that he has filed an early warning report (the "Early Warning Report") under National Instrument 62-103 – The Early Warning System and Related Take-Over Bid and Insider …

Celularity Receives Nasdaq Notice Regarding Form 10-Q

Celularity Receives Nasdaq Notice Regarding Form 10-Q

FLORHAM PARK, N.J., May 30, 2025 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity” or the “Company”), a cellular and regenerative medicine company, today announced that on May 28, 2025, Nasdaq notified the Company that it did not timely file …

COSCIENS Biopharma Inc. Reconstitutes Board for Benefit of Shareholders

COSCIENS Biopharma Inc. Reconstitutes Board for Benefit of Shareholders

Reconstituted Board to Revitalize COSCIENS TORONTO, May 30, 2025 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (NASDAQ: CSCI; TSX: CSCI) today announced that it has entered into a resolution agreement (the “Resolution Agreement”) with Goodwood Inc., Goodwood …

Fate Therapeutics Appoints Matthew Abernethy, M.B.A., to its Board of Directors

Fate Therapeutics Appoints Matthew Abernethy, M.B.A., to its Board of Directors

SAN DIEGO, May 30, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a pipeline of induced pluripotent stem cell (iPSC)-derived off-the-shelf cellular immunotherapies to …

Publication relating to transparency notifications

Publication relating to transparency notifications

                 REGULATED INFORMATION Publication relating to transparency notifications Mont-Saint-Guibert (Belgium), May 30, 2025, 10:30 pm CET / 4:30 pm ET – In accordance with article 14 of the Act of 2 May 2007 on the disclosure of large …

Publication relative à des notifications de transparence

Publication relative à des notifications de transparence

         INFORMATION RÉGLEMENTÉE Publication relative à des notifications de transparence Mont-Saint-Guibert (Belgique), le 30 mai 2025, 22:30h CET / 16:30h ET – Conformément à l'article 14 de la loi du 2 mai 2007 relative à la publicité des participations …

Plus Therapeutics Reports First Quarter Financial Results and Recent Business Highlights

Plus Therapeutics Reports First Quarter Financial Results and Recent Business Highlights

Company continues to progress both REYOBIQ™ radiotherapeutic clinical trials and CNSide® CSF assay platform launch readiness HOUSTON, May 30, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), a clinical-stage …

NurExone Announces Clinical Trial Plans for Acute Spinal Cord Injury Therapy at Annual Meeting of American Spinal Injury Association

NurExone Announces Clinical Trial Plans for Acute Spinal Cord Injury Therapy at Annual Meeting of American Spinal Injury Association

TORONTO and HAIFA, Israel, May 30, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”) is pleased to announce that Professor Nahshon Knoller M.D., senior clinical advisor to the Company, will …

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

VANCOUVER, British Columbia and BOSTON, May 30, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for …

Kymera Therapeutics to Announce KT-621 Phase 1 Healthy Volunteer Trial Results on June 2, 2025

Kymera Therapeutics to Announce KT-621 Phase 1 Healthy Volunteer Trial Results on June 2, 2025

WATERTOWN, Mass., May 30, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, will announce results from …

Tevogen Details its Artificial Intelligence Initiative, Tevogen.AI; Proprietary AI-Powered Immunotherapy with Microsoft and Databricks Partnerships

Tevogen Details its Artificial Intelligence Initiative, Tevogen.AI; Proprietary AI-Powered Immunotherapy with Microsoft and Databricks Partnerships

WARREN, N.J., May 30, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today provided stockholders with a detailed overview of its artificial intelligence initiative, Tevogen.AI™. Tevogen.AI™ aims to integrate …

America’s Blood Centers and ACS Stop the Bleed Announce New National Collaboration

America’s Blood Centers and ACS Stop the Bleed Announce New National Collaboration

Washington, DC, May 30, 2025 (GLOBE NEWSWIRE) -- America’s Blood Centers (ABC), the national organization of community-based, independent blood centers that supply 60 percent of the nation’s blood supply, and the American College of Surgeons (ACS) Stop the …

Fortress Biotech Announces Closing of Sale of Subsidiary Checkpoint Therapeutics

Fortress Biotech Announces Closing of Sale of Subsidiary Checkpoint Therapeutics

MIAMI, May 30, 2025 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value for shareholders through product revenue, equity …

PESG Research Report: Revolutionary Surgical Infection Prevention: PolyPid’s D-PLEX100 Approaches Critical Phase 3 Data Readout

PESG Research Report: Revolutionary Surgical Infection Prevention: PolyPid’s D-PLEX100 Approaches Critical Phase 3 Data Readout

New York, May 30, 2025 (GLOBE NEWSWIRE) -- PESG Research is releasing a report  today examining PolyPid Ltd.*, an innovative late-stage biopharmaceutical company developing revolutionary localized drug delivery technologies for surgical infection …

Legend Senior Living® Grows Portfolio Across Kansas, Colorado, and Pennsylvania

Legend Senior Living® Grows Portfolio Across Kansas, Colorado, and Pennsylvania

WICHITA, Kan., May 30, 2025 (GLOBE NEWSWIRE) -- Legend Senior Living, a national senior housing provider headquartered in Wichita, Kansas, has announced it will assume management of four additional communities, expanding its growing portfolio. The …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service